Filing Details
- Accession Number:
- 0000899243-21-044611
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-15 17:07:13
- Reporting Period:
- 2021-11-11
- Accepted Time:
- 2021-11-15 17:07:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501134 | Invitae Corp | NVTA | Services-Medical Laboratories (8071) | 271701898 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1640322 | L Robert Nussbaum | C/O Invitae Corporation 1400 16Th Street San Francisco CA 94103 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-11 | 13,269 | $9.90 | 259,319 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-11-11 | 16,406 | $10.23 | 275,725 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-11-11 | 29,675 | $21.89 | 246,050 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Options (right to buy) | Disposition | 2021-11-11 | 13,269 | $0.00 | 13,269 | $9.90 |
| Common Stock | Employee Stock Options (right to buy) | Disposition | 2021-11-11 | 16,406 | $0.00 | 16,406 | $10.23 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 40,080 | 2025-08-04 | No | 4 | M | Direct | |
| 53,594 | 2026-03-31 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2021.
- Represents a weighted average sale price. Actual sale prices ranged from $21.62 to $22.30 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Includes an aggregate of 84,134 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- The shares subject to this option are fully vested and exercisable.
- The shares subject to this option are fully vested and exercisable.
Billionaire Hedge Funds
